1-13 of 13
Gabriella Gruden
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Natriuretic Peptides, Heart, and Adipose Tissue: New Findings and Future Developments for Diabetes Research

Gabriella Gruden, Andrea Landi, Graziella Bruno
Journal: Diabetes Care
Diabetes Care 2014;37(11):2899–2908
https://doi.org/10.2337/dc14-0669
Published: 10 October 2014
View article titled, Natriuretic Peptides, Heart, and Adipose Tissue: New Findings and Future Developments for Diabetes Research
Open the PDF for Natriuretic Peptides, Heart, and Adipose Tissue: New Findings and Future Developments for Diabetes Research in another window
Journal Articles

N-Terminal Probrain Natriuretic Peptide Is a Stronger Predictor of Cardiovascular Mortality Than C-Reactive Protein and Albumin Excretion Rate in Elderly Patients With Type 2 Diabetes: The Casale Monferrato population-based study

Graziella Bruno, MD, Andrea Landi, MD, Federica Barutta, PHD, Giuseppe Ghezzo, MD, Claudio Baldin, BSC, Laura Spadafora, MD, Andrea Schimmenti, MD, Tania Prinzis, MD, Paolo Cavallo Perin, MD, Gabriella Gruden, PHD
Journal: Diabetes Care
Diabetes Care 2013;36(9):2677–2682
https://doi.org/10.2337/dc13-0353
Published: 13 August 2013
View article titled, N-Terminal Probrain Natriuretic Peptide Is a Stronger Predictor of Cardiovascular Mortality Than C-Reactive Protein and Albumin Excretion Rate in Elderly Patients With Type 2 Diabetes: <subtitle>The Casale Monferrato population-based study</subtitle>
Open the PDF for N-Terminal Probrain Natriuretic Peptide Is a Stronger Predictor of Cardiovascular Mortality Than C-Reactive Protein and Albumin Excretion Rate in Elderly Patients With Type 2 Diabetes: <subtitle>The Casale Monferrato population-based study</subtitle> in another window
Journal Articles

Response to Comment on: Gruden et al. Severe Hypoglycemia and Cardiovascular Disease Incidence in Type 1 Diabetes: The EURODIAB Prospective Complications Study. Diabetes Care 2012;35:1598–1604

Gabriella Gruden, PHD, Federica Barutta, PHD, Paolo Cavallo Perin, MD, Graziella Bruno, MD
Journal: Diabetes Care
Diabetes Care 2012;35(12):e89
https://doi.org/10.2337/dc12-1500
Published: 14 November 2012
View article titled, Response to Comment on: Gruden et al. Severe Hypoglycemia and Cardiovascular Disease Incidence in Type 1 Diabetes: The EURODIAB Prospective Complications Study. Diabetes Care 2012;35:1598–1604
Open the PDF for Response to Comment on: Gruden et al. Severe Hypoglycemia and Cardiovascular Disease Incidence in Type 1 Diabetes: The EURODIAB Prospective Complications Study. Diabetes Care 2012;35:1598–1604 in another window
Journal Articles

Rate and Determinants of Association Between Advanced Retinopathy and Chronic Kidney Disease in Patients With Type 2 Diabetes: The Renal Insufficiency And Cardiovascular Events (RIACE) Italian multicenter study

Giuseppe Penno, MD, Anna Solini, MD, Giacomo Zoppini, MD, Emanuela Orsi, MD, Gianpaolo Zerbini, MD, Roberto Trevisan, MD, Gabriella Gruden, MD, Franco Cavalot, MD, Luigi Laviola, MD, Susanna Morano, MD, Antonio Nicolucci, MD, Giuseppe Pugliese, MD, for the Renal Insufficiency And Cardiovascular Events (RIACE) Study Group
Journal: Diabetes Care
Diabetes Care 2012;35(11):2317–2323
https://doi.org/10.2337/dc12-0628
Published: 13 October 2012
View article titled, Rate and Determinants of Association Between Advanced Retinopathy and Chronic Kidney Disease in Patients With Type 2 Diabetes: <subtitle>The Renal Insufficiency And Cardiovascular Events (RIACE) Italian multicenter study</subtitle>
Open the PDF for Rate and Determinants of Association Between Advanced Retinopathy and Chronic Kidney Disease in Patients With Type 2 Diabetes: <subtitle>The Renal Insufficiency And Cardiovascular Events (RIACE) Italian multicenter study</subtitle> in another window
Includes: Supplementary data
Journal Articles

NH2-Terminal Probrain Natriuretic Peptide Is Associated With Diabetes Complications in the EURODIAB Prospective Complications Study: The role of tumor necrosis factor-α

Gabriella Gruden, PHD, Federica Barutta, PHD, Nish Chaturvedi, MRCP, Casper Schalkwijk, PHD, Coen D. Stehouwer, PHD, Silvia Pinach, MSC, Maria Manzo, BSC, Maria Loiacono, BSC, Marinella Tricarico, MD, Giulio Mengozzi, MD, Daniel R. Witte, PHD, John H. Fuller, FRCP, Paolo Cavallo Perin, MD, Graziella Bruno, MD
Journal: Diabetes Care
Diabetes Care 2012;35(9):1931–1936
https://doi.org/10.2337/dc12-0089
Published: 14 August 2012
View article titled, NH<sub>2</sub>-Terminal Probrain Natriuretic Peptide Is Associated With Diabetes Complications in the EURODIAB Prospective Complications Study: <subtitle>The role of tumor necrosis factor-α</subtitle>
Open the PDF for NH<sub>2</sub>-Terminal Probrain Natriuretic Peptide Is Associated With Diabetes Complications in the EURODIAB Prospective Complications Study: <subtitle>The role of tumor necrosis factor-α</subtitle> in another window
Includes: Supplementary data
Journal Articles

Severe Hypoglycemia and Cardiovascular Disease Incidence in Type 1 Diabetes: The EURODIAB Prospective Complications Study

Gabriella Gruden, PHD, Federica Barutta, PHD, Nish Chaturvedi, MRCP, Casper Schalkwijk, PHD, Coen D. Stehouwer, PHD, Daniel R. Witte, PHD, John H. Fuller, FRCP, Paolo Cavallo Perin, MD, Graziella Bruno, MD
Journal: Diabetes Care
Diabetes Care 2012;35(7):1598–1604
https://doi.org/10.2337/dc11-1531
Published: 12 June 2012
View article titled, Severe Hypoglycemia and Cardiovascular Disease Incidence in Type 1 Diabetes: <subtitle>The EURODIAB Prospective Complications Study</subtitle>
Open the PDF for Severe Hypoglycemia and Cardiovascular Disease Incidence in Type 1 Diabetes: <subtitle>The EURODIAB Prospective Complications Study</subtitle> in another window
Includes: Supplementary data
Journal Articles

Increased QT Interval Dispersion Predicts 15-Year Cardiovascular Mortality in Type 2 Diabetic Subjects: The population-based Casale Monferrato Study

Sara Giunti, PHD, Gabriella Gruden, PHD, Paolo Fornengo, MD, Federica Barutta, PHD, Cristina Amione, MD, Giuseppe Ghezzo, MD, Paolo Cavallo-Perin, MD, Graziella Bruno, MD
Journal: Diabetes Care
Diabetes Care 2012;35(3):581–583
https://doi.org/10.2337/dc11-1397
Published: 10 February 2012
View article titled, Increased QT Interval Dispersion Predicts 15-Year Cardiovascular Mortality in Type 2 Diabetic Subjects: <subtitle>The population-based Casale Monferrato Study</subtitle>
Open the PDF for Increased QT Interval Dispersion Predicts 15-Year Cardiovascular Mortality in Type 2 Diabetic Subjects: <subtitle>The population-based Casale Monferrato Study</subtitle> in another window
Journal Articles

QTc Interval Prolongation Is Independently Associated With Severe Hypoglycemic Attacks in Type 1 Diabetes From the EURODIAB IDDM Complications Study

Gabriella Gruden, PHD, Sara Giunti, PHD, Federica Barutta, PHD, Nish Chaturvedi, MRCP, Daniel R. Witte, PHD, Marinella Tricarico, MD, John H. Fuller, FRCP, Paolo Cavallo Perin, MD, Graziella Bruno, MD
Journal: Diabetes Care
Diabetes Care 2012;35(1):125–127
https://doi.org/10.2337/dc11-1739
Published: 09 December 2011
View article titled, QTc Interval Prolongation Is Independently Associated With Severe Hypoglycemic Attacks in Type 1 Diabetes From the EURODIAB IDDM Complications Study
Open the PDF for QTc Interval Prolongation Is Independently Associated With Severe Hypoglycemic Attacks in Type 1 Diabetes From the EURODIAB IDDM Complications Study in another window
Includes: Supplementary data
Journal Articles

Anti–Heat Shock Protein 27 Antibody Levels and Diabetes Complications in the EURODIAB Study

Davina Burt, PHD, Graziella Bruno, MD, Nish Chaturvedi, MRCP, Casper Schalkwijk, PHD, Coen D. Stehouwer, PHD, Daniel R. Witte, PHD, John H. Fuller, FRCP, Silvia Pinach, MSC, Paolo Cavallo Perin, MD, Gabriella Gruden, PHD
Journal: Diabetes Care
Diabetes Care 2009;32(7):1269–1271
https://doi.org/10.2337/dc08-2271
Published: 14 April 2009
View article titled, Anti–Heat Shock Protein 27 Antibody Levels and Diabetes Complications in the EURODIAB Study
Open the PDF for Anti–Heat Shock Protein 27 Antibody Levels and Diabetes Complications in the EURODIAB Study in another window
Journal Articles

Incidence and Risk Factors of Prolonged QTc Interval in Type 1 Diabetes: The EURODIAB Prospective Complications Study

Sara Giunti, MD, Graziella Bruno, MD, Emma Lillaz, MD, Gabriella Gruden, MD, Valentina Lolli, MD, Nish Chaturvedi, MD, John H. Fuller, MD, Massimo Veglio, MD, Paolo Cavallo-Perin, MD, The EURODIAB IDDM Complications Study Group
Journal: Diabetes Care
Diabetes Care 2007;30(8):2057–2063
https://doi.org/10.2337/dc07-0063
Published: 01 August 2007
View article titled, Incidence and Risk Factors of Prolonged QTc Interval in Type 1 Diabetes: <subtitle>The EURODIAB Prospective Complications Study</subtitle>
Open the PDF for Incidence and Risk Factors of Prolonged QTc Interval in Type 1 Diabetes: <subtitle>The EURODIAB Prospective Complications Study</subtitle> in another window
Journal Articles

Electrocardiographic Left Ventricular Hypertrophy in Type 1 Diabetes: Prevalence and relation to coronary heart disease and cardiovascular risk factors: the Eurodiab IDDM Complications Study

Sara Giunti, MD, Graziella Bruno, MD, Massimo Veglio, MD, Gabriella Gruden, MD, PHD, David J. Webb, MSC, Shona Livingstone, MSC, Nish Chaturvedi, MRCP, MD, John H. Fuller, FRCP, Paolo Cavallo Perin, MD, the EURODIAB IDDM Complications Study Group
Journal: Diabetes Care
Diabetes Care 2005;28(9):2255–2257
https://doi.org/10.2337/diacare.28.9.2255
Published: 01 September 2005
View article titled, Electrocardiographic Left Ventricular Hypertrophy in Type 1 Diabetes: <subtitle>Prevalence and relation to coronary heart disease and cardiovascular risk factors: the Eurodiab IDDM Complications Study</subtitle>
Open the PDF for Electrocardiographic Left Ventricular Hypertrophy in Type 1 Diabetes: <subtitle>Prevalence and relation to coronary heart disease and cardiovascular risk factors: the Eurodiab IDDM Complications Study</subtitle> in another window
Journal Articles

Activated Protein C Resistance in Type I Diabetes

Gabriella Gruden, MD, Carla Olivetti, MD, Paolo Cavallo-Perin, MD, Mario Bazzan, MD, Stefania Stella, MD, Giacomo Tamponi, MD, Gianfranco Pagano, MD
Journal: Diabetes Care
Diabetes Care 1997;20(3):424–425
https://doi.org/10.2337/diacare.20.3.424
Published: 01 March 1997
View article titled, Activated Protein C Resistance in Type I Diabetes
Open the PDF for Activated Protein C Resistance in Type I Diabetes in another window
Journal Articles

Lipoprotein(a) and Insulin Treatment in NIDDM Patients

Gabriella Gruden, MD, Massimo Veglio, MD, Paolo Cavallo-Perin, MD, Carla Olivetti, MD, Alberto Mormile, MD, Maurizio Cassader, PHD, Gianfranco Pagano, MD
Journal: Diabetes Care
Diabetes Care 1994;17(9):1075–1076
https://doi.org/10.2337/diacare.17.9.1075b
Published: 01 September 1994
View article titled, Lipoprotein(a) and Insulin Treatment in NIDDM Patients
Open the PDF for Lipoprotein(a) and Insulin Treatment in NIDDM Patients in another window